Company Filing History:
Years Active: 2007
Title: Uwe Schönbeck: Innovator in Cardiovascular Diagnostics
Introduction
Uwe Schönbeck is a notable inventor based in Randolph, MA (US). He has made significant contributions to the field of cardiovascular diagnostics, particularly through his innovative patent related to atherosclerotic diseases. His work aims to improve the understanding and treatment of cardiovascular disorders.
Latest Patents
Uwe Schönbeck holds a patent titled "Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases." This invention involves a new use of a diagnostic test that determines the risk of atherosclerotic diseases, such as myocardial infarction and stroke. This is particularly relevant for individuals who show no signs or symptoms of current disease and among nonsmokers. The diagnostic test assists physicians in identifying which individuals at risk will benefit from specific treatments designed to prevent first or recurrent myocardial infarctions and strokes, or to treat acute and chronic cardiovascular disorders. Methods for treatment are also described in this patent.
Career Highlights
Uwe Schönbeck is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance research in cardiovascular health. His work has been instrumental in developing diagnostic tools that can significantly impact patient care and treatment outcomes.
Collaborations
Uwe Schönbeck has collaborated with esteemed colleagues, including Paul M. Ridker and Peter Libby. These collaborations have further enhanced the research and development of innovative solutions in the field of cardiovascular medicine.
Conclusion
Uwe Schönbeck's contributions to cardiovascular diagnostics through his patent demonstrate his commitment to improving patient outcomes. His innovative approach to understanding atherosclerotic diseases is paving the way for more effective treatments and diagnostic methods.